Dynatronics Corporation (DYNT)

Add to Watchlists Create an Alert
2.584 -0.10  -3.58%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Dynatronics Corporation R&D Expense Quarterly:

0.2744M for Dec. 31, 2012
View Full Chart

Dynatronics Corporation R&D Expense Quarterly Chart

    Dynatronics Corporation Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    Dec. 31, 2012 0.2744M
    Sept. 30, 2012 0.2663M
    June 30, 2012 0.2793M
    March 31, 2012 0.3619M
    Dec. 31, 2011 0.4129M
    Sept. 30, 2011 0.3563M
    June 30, 2011 0.3381M
    March 31, 2011 0.3393M
    Dec. 31, 2010 0.3565M
    Sept. 30, 2010 0.3498M
    June 30, 2010 0.27M
    March 31, 2010 0.2221M
    Dec. 31, 2009 0.2069M
    Sept. 30, 2009 0.216M
    June 30, 2009 0.2183M
    March 31, 2009 0.2473M
    Dec. 31, 2008 0.2657M
    Sept. 30, 2008 0.262M
    June 30, 2008 0.2838M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
       
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    DYNT R&D Expense Quarterly Benchmarks

    Companies
    Abiomed 6.822M
    Guided Therapeutics 0.83M
    Span-America Medical 0.3228M

    DYNT R&D Expense Quarterly Rankings

    Overall 81st percentile
    1468 of 8011
    Sector 33rd percentile
    459 of 687 in Healthcare
    Industry 21st percentile
    73 of 93 in Medical Devices

    DYNT R&D Expense Quarterly Range, Past 5 Years

    Minimum 0.2069M Dec 2009
    Maximum 0.4129M Dec 2011
    Average 0.2909M